Group Profile

Group Profile

Group Profile

As a technology-driven comprehensive service provider for the whole chain pharmaceutical industry, Jointown is based on the comprehensive health industry. Its main business comprises the following six parts: digital pharmaceutical distribution and supply chain business, general agency brand promotion business, pharmaceutical industrial self-production and OEM business, new retail and Ten-Thousand Store Alliance Plan business (C-end), medical health (C-end) and technology value-added services, and digital logistics technology and supply chain solutions. Jointown has taken the lead in the transformation and upgrading of the pharmaceutical distribution business from a traditional model to a digitalized, platform-centered and Internet-based model in the industry, and achieved significant results. The Company has promoted the transformation and upgrading from the single pharmaceutical distribution business to multi-format businesses, such as pharmaceutical CSO, pharmaceutical new retail, and pharmaceutical industry. Jointown has built a rare "hundred-billion level" pharmaceutical supply chain service platform in the industry, and completed the business layout of full-variety procurement, full-channel coverage and full-scenario services. Relying on the resource advantages of its "hundred-billion level" platform, the Company takes efforts to create the whole industry chain of pharmaceuticals, with a new pattern of integrated development of "pharmaceutical distribution + multiple business formats". Jointown further accelerates the business growth based on the six main business layouts, gradually forming a comprehensive health service platform for B-end and C-end users, which is characterized by multiple business formats and platforms, "integration of wholesale and retail", "BC integration", and integration of online and offline services. Jointown has strongly promoted the strategies of "new products, new retail, new medical services, digitalization, and real estate securitization" (Three News and Two Transformations), continuously improving the quality and efficiency of the development of featured businesses. Jointown follows the principle of "pursuing progress while ensuring stability" to open a new situation, with business innovation driving growth and digital management improving quality and efficiency. In the future, Jointown will continue to promote the comprehensive service model of "pharmaceutical distribution + logistics distribution + product promotion", follow the emerging trends in the market and take actions accordingly to maintain a robust growth. 

billion RMB
Operating Income in the first 3 quarters of 2024
billion RMB
Net Income Attributable (Excl. Excep)
billion RMB
Total Assets

Group Profile

Group Profile

Group Profile

As a technology-driven comprehensive service provider for the whole chain pharmaceutical industry, Jointown is based on the comprehensive health industry. Its main business comprises the following six parts: digital pharmaceutical distribution and supply chain business, general agency brand promotion business, pharmaceutical industrial self-production and OEM business, new retail and Ten-Thousand Store Alliance Plan business (C-end), medical health (C-end) and technology value-added services, and digital logistics technology and supply chain solutions. Jointown has taken the lead in the transformation and upgrading of the pharmaceutical distribution business from a traditional model to a digitalized, platform-centered and Internet-based model in the industry, and achieved significant results. The Company has promoted the transformation and upgrading from the single pharmaceutical distribution business to multi-format businesses, such as pharmaceutical CSO, pharmaceutical new retail, and pharmaceutical industry. Jointown has built a rare "hundred-billion level" pharmaceutical supply chain service platform in the industry, and completed the business layout of full-variety procurement, full-channel coverage and full-scenario services. Relying on the resource advantages of its "hundred-billion level" platform, the Company takes efforts to create the whole industry chain of pharmaceuticals, with a new pattern of integrated development of "pharmaceutical distribution + multiple business formats". Jointown further accelerates the business growth based on the six main business layouts, gradually forming a comprehensive health service platform for B-end and C-end users, which is characterized by multiple business formats and platforms, "integration of wholesale and retail", "BC integration", and integration of online and offline services. Jointown has strongly promoted the strategies of "new products, new retail, new medical services, digitalization, and real estate securitization" (Three News and Two Transformations), continuously improving the quality and efficiency of the development of featured businesses. Jointown follows the principle of "pursuing progress while ensuring stability" to open a new situation, with business innovation driving growth and digital management improving quality and efficiency. In the future, Jointown will continue to promote the comprehensive service model of "pharmaceutical distribution + logistics distribution + product promotion", follow the emerging trends in the market and take actions accordingly to maintain a robust growth. 

billion RMB
Operating Income in the first 3 quarters of 2024
billion RMB
Net Income Attributable (Excl. Excep)
billion RMB
Total Assets